On 2026-09-23, Jefferies raised its VRTX price target to $640.
Jefferies 于 2026-09-23 将 VRTX 目标价上调至 $640。
For information only. Not investment advice.内容仅供参考，不构成投资建议。
UBS raises VRTX target to $615 from $585UBS 上调目标价 福泰制药 (VRTX)：$585 → $615
Rating Change · September 28, 2026评级变动 · 2026/9/28
VERTEX PHARMACEUTICALS INC / MA files 8-K Item 5.02 executive-change disclosure福泰制药 (VRTX) 提交 8-K Item 5.02 高管变动披露
SEC Material Disclosure · September 1, 2026SEC 重大披露 · 2026/9/1
VRTX definitive M&A: Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership TeamVertex Pharmaceuticals Incorporated（VRTX）披露确定性并购进展
Material Company Event · September 1, 2026公司公告 · 2026/9/1
